Max Cost Of Revenue from 2010 to 2024

MAXHEALTH   1,168  35.50  3.14%   
Max Healthcare Cost Of Revenue yearly trend continues to be quite stable with very little volatility. Cost Of Revenue may rise above about 21.6 B this year. From the period between 2010 and 2024, Max Healthcare, Cost Of Revenue regression line of its data series had standard deviation of  5,751,096,168 and standard deviation of  5,751,096,168. View All Fundamentals
 
Cost Of Revenue  
First Reported
2017-06-30
Previous Quarter
10 B
Current Value
10.7 B
Quarterly Volatility
2.8 B
 
Covid
Check Max Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Max Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 B, Interest Expense of 954.1 M or Selling And Marketing Expenses of 3.9 B, as well as many indicators such as . Max financial statements analysis is a perfect complement when working with Max Healthcare Valuation or Volatility modules.
  
This module can also supplement various Max Healthcare Technical models . Check out the analysis of Max Healthcare Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Max Stock

Max Healthcare financial ratios help investors to determine whether Max Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Max with respect to the benefits of owning Max Healthcare security.